Gavin B. Bart

Integrated Governance of the Synthetic Opioid Crisis: A Comparative Review From a Public Health Perspective in the United States and China

Wei Hao, Peter Jackson, Gavin B. Bart

Abstract Purpose of Review The rapid proliferation of synthetic opioids, particularly fentanyl and its analogues, has intensified the opioid crisis, highlighted the limitations of fragmented approaches to opioid use disorder (OUD), and heightened tensions between the United States and China. This narrative …

cn, cz, us (code pays fourni par la source)

Primary care clinicians' perspectives on an electronic health record-integrated clinical decision support tool for opioid use disorder

Gavin B. Bart, Gavin Bart, Caitlin M. Borgert-Spaniol, A. Lauren Crain et autres

us (code pays fourni par la source)

Perspectives on Clinical Champions Implementing Hospital-Based Opioid Treatment in US Hospitals

Linda Peng, Amelia Goff, Alisa Patten, Angela R Bazzi et autres

Importance: Hospital-based opioid treatment (HBOT) can improve outcomes for patients with opioid use disorder, but little is known about specific attributes and supports needed for clinical champions to successfully implement HBOT. Objective: To identify characteristics and supports of effective clinical champions implementing …

us (code pays fourni par la source)

External Validation of Epic’s Risk of Opioid Abuse and Overdose Model Among Primary Care Patients in Three Health Systems

Stephanie A. Hooker, Rebecca C. Rossom, Jacob Haapala, A. Lauren Crain et autres

us (code pays fourni par la source)

Patient Impressions of Opioid-Related Printouts, Discussions and Care in a Primary Care Clinical Decision Support System Implementation Trial

Rebecca C. Rossom, Jacob Happala, Clayton Allen, Jennifer McCormack et autres

Primary care is a critical setting to provide care for the 75-79% of patients who have opioid use disorder (OUD) but do not receive medications for OUD. However, patient perceptions of primary care of OUD are not well understood. Patients completed surveys …

Abstract 4371709: Cardiovascular Interventions and Mortality in Recurrent Infective Endocarditis and Substance Use Disorder: The Paradox of Procedure

Karim Ali, Charles Reznikoff, Gavin B. Bart, Gautam R. Shroff

Background: Infective endocarditis (IE) recurrence is common among patients with substance use disorder (SUD) and is often met with repeated cardiac interventions due to their young age and perceived procedural candidacy. However, the impact of such interventions on survival remains unclear, particularly …

us (code pays fourni par la source)

Factors associated with mortality following hospitalization among veterans with opioid use disorder

Michael A. Incze, Sophia Huebler, Jacob D. Baylis, Andrea Stofko et autres

us (code pays fourni par la source)

Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial

Manish K. Jha, Udi E. Ghitza, Steve Shoptaw, Abu Minhajuddin et autres

This study evaluated whether depressive symptom severity improved early with extended-release naltrexone and bupropion combination (naltrexone bupropion) compared to a placebo in individuals with moderate/severe methamphetamine use disorder and predicted subsequent use of methamphetamine. This secondary analysis from the Accelerated Development of …

us (code pays fourni par la source)

Clinical Decision Support System for Primary Care of Opioid Use Disorder

Rebecca C. Rossom, A. Lauren Crain, Eric A. Wright, Anthony W. Olson et autres

Importance: Nearly 727 000 individuals in the US died of opioid overdoses between 1999 and 2022. The current workforce of addiction medicine specialists is inadequate to address the scale of this crisis, and primary care clinicians (PCCs) do not feel sufficiently supported …

us (code pays fourni par la source)

Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial

Manish K. Jha, Udi E. Ghitza, Thomas James Carmody, STEVEN J. SHOPTAW et autres

OBJECTIVES: The accelerated development of additive pharmacotherapy treatment (ADAPT-2) for methamphetamine use disorder (MUD) trial demonstrated the efficacy of extended-release injectable naltrexone (NTX) and oral bupropion (BUP). In this secondary analysis, we determined whether craving and impulsivity levels could predict subsequent use …

“When She’s there, I No Longer Worry about Her Being arrested” – Family Perspectives on Compulsory Drug Rehabilitation in Vietnam and Implications for Community-Based Approaches

Trang Nguyen, Hoe Han, Anh Nguyen, Gavin B. Bart et autres

vn, Nigéria, us (code pays fourni par la source)

Engaging African American Faith-Based Leaders in a Substance Use Learning Collaborative (LC)

Holly Hagle, Dawn Tyus, An‐Lin Cheng, Kaleea R. Lewis et autres

us, be, tr (code pays fourni par la source)